Cytotoxic analysis using a panel of cancer cell lines with different combinations of MET and EGFR expression show that both dual targeting ADCs are effective in killing cancer cells with IC50 values ranging from 0.4 to 1.0 nM/L [82]. This evidence concerns the gene EGFR and cancer.